A recent Medgadget article reported on a new device aimed at combating the opioid crisis. The RESPMETER wearable biosensor from Altair Medical just achieved a breakthrough device designation from the FDA. The device is a wireless sensor that is worn on a patient’s chest to detect Opioid Induced Respiratory Depression (OIRD), a common deadly side effect associated with the use of opioid drugs. When the RESPMETER detects signs of OIRD, it notifies designated first responders who can intervene by administering naloxone.
Quick Hits: FDA Gives Opioid Overdose Detector Breakthrough Status
The device contains a biosensor that detects fatal side effects of opioid abuse.
Mar 13, 2020
Recommended
Recommended
Recommended
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
